What is the ticker symbol for Bone Biologics?

Bone Biologics trades under the ticker BBLG on NASDAQ.

What sector does Bone Biologics operate in?

Bone Biologics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze BBLG in a portfolio?

PortView shows BBLG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Bone Biologics (BBLG) Stock Analysis

NASDAQHealthcareBiotechnology

$0.56-0.75%

1-year price historyRange $0.56 – $2.85

52-week range$0.56

$0.54$4.13

What Bone Biologics does

Bone Biologics Corporation, a medical device enterprise, specializes in fostering bone regeneration for spinal fusion, leveraging its advanced recombinant human protein technology. Its flagship product, NELL-1/DBX, is a unique combination of an osteostimulative recombinant protein designed for precise, targeted control over bone regrowth. The company is currently advancing the NELL-1/DBX Fusion Device, intended for spinal fusion interventions in skeletally mature individuals experiencing single-level degenerative disc disease within the L4-S1 spinal segments. This versatile platform technology also holds the potential to deliver superior outcomes across a wide spectrum of surgical specialties, including spinal, various orthopedic fields, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. Bone Biologics holds a licensing agreement with the UCLA Technology Development Group, which authorizes the development and commercialization of NELL-1 for its spinal fusion applications. The firm was established in 2004 and is based in Burlington, Massachusetts.

Key metrics

Market cap

$1.01M

P/E (TTM)

-0.25

EPS (TTM)

$-2.27

Beta

0.53

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$1.00

200-day avg

$1.32

52-week high

$4.13

52-week low

$0.54

CEO

Jeffrey Frelick

ETFs linked to BBLG

Broad-market and Healthcare sector ETFs an investor holding Bone Biologics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BBLG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BBLG in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Bone Biologics?: Bone Biologics trades under the ticker BBLG on NASDAQ.
Which exchange is BBLG listed on?: BBLG is listed on NASDAQ.
What sector does Bone Biologics operate in?: Bone Biologics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze BBLG in a portfolio?: PortView shows BBLG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.